Literature DB >> 1499640

Incomplete suppression of hepatic glucose production in non-insulin dependent diabetes mellitus measured with [6,6-2H2]glucose enriched glucose infusion during hyperinsulinaemic euglycaemic clamps.

J K Powrie1, G D Smith, T R Hennessy, F Shojaee-Moradie, J M Kelly, P H Sönksen, R H Jones.   

Abstract

We have minimized methodological errors in the isotope dilution technique by using stable isotope, [6,6-2H2]glucose, thus avoiding the problem of contamination of tritiated glucose tracers and, by maintaining a constant plasma tracer enrichment have reduced error due to mixing transients. Using these modifications we have calculated hepatic glucose production in 20 patients with non-insulin-dependent diabetes mellitus during low (1 mU kg-1 min-1) and high (8 mU kg-1 min-1) dose insulin infusions. Mean fasting hepatic glucose production was 14.2 +/- 0.8 mumol kg-1 min-1. This suppressed by only 68% to 4.6 +/- 0.8 mumol kg-1 min-1 during the low-dose insulin infusion (plasma insulin 0.85 +/- 0.05 nmol l-1) and did not suppress further during the high-dose insulin infusion (plasma insulin 14.55 +/- 0.83 nmol l-1). Hepatic glucose production was significantly higher than zero throughout the study. Thus, we have found that minimization of known errors in the isotope dilution technique results in physiologically plausible and significantly positive values for hepatic glucose production indicating that the liver is resistant to insulin in patients with non-insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499640     DOI: 10.1111/j.1365-2362.1992.tb01458.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects.

Authors:  H B Holt; S H Wild; P J Wood; J Zhang; A A Darekar; K Dewbury; R B Poole; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

2.  Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus.

Authors:  N M O'Meara; J Sturis; E Van Cauter; K S Polonsky
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

3.  Gender differences in counterregulation to hypoglycaemia.

Authors:  S A Amiel; A Maran; J K Powrie; A M Umpleby; I A Macdonald
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

4.  Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance.

Authors:  T S Berrish; C S Hetherington; K G Alberti; M Walker
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

5.  Characteristics of glucose metabolism in Nordic and South Asian subjects with type 2 diabetes.

Authors:  Cecilie Wium; Hanne Løvdal Gulseth; Erik Fink Eriksen; Kåre Inge Birkeland
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

6.  Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men.

Authors:  H B Holt; S H Wild; A D Postle; J Zhang; G Koster; M Umpleby; F Shojaee-Moradie; K Dewbury; P J Wood; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2007-03-17       Impact factor: 10.122

7.  Differential effects of fatness, fitness and physical activity energy expenditure on whole-body, liver and fat insulin sensitivity.

Authors:  H B Holt; S H Wild; N Wareham; U Ekelund; M Umpleby; F Shojaee-Moradie; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2007-05-30       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.